MAP2K7 and hepatocellular carcinoma: Indeed, HOXA-AS3 knockdown was previously shown to inhibit the proliferation, metastasis, and EMT in hepatocellular carcinoma (HCC) cells via the MEK/ERK signaling pathway (34).